HIGHLIGHTS
- who: Hing Yu Hung from the Hong Kong Institute of Integrative Medicine, Faculty of Medicine, The Chinese University of Hong Kong, Shatin, NT, Hong Kong SAR, China have published the paper: Efficacy and safety of modified Xiao-Feng Powder in the treatment of chronic urticaria: protocol of a randomized double-blind placebo-controlled study, in the Journal: Gut microbiota of July/19,/2021
- what: The authors aim to investigate the effectiveness and safety of modified Xiao-Feng Powder (mXFP) for the treatment of CU.
SUMMARY
In 2012, the China State Administration . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.